PA
Phibro Animal Health Corporation
PAHC · NASDAQ
$35.62 -4.78% (-$1.79)
1M +4.58%
Market Cap $1.48B
P/E Ratio 14.87x
Div. Yield 1.31%
ROE 28.67%
Bulios Fair Price
$38.3
7.5% upside
Current Price
$35.62
Undervalued Fair Value Overvalued
According to Bulios Fair Price, PAHC is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
6/9Valuation
63 /100
Fair P/FCF 150.30x
P/E 14.87x
P/B 3.85x
Growth
94 /100
Growing Book val. growth 10.91%
EPS growth 44.42%
Rev. growth 15.79%
Profitability
41 /100
Moderate Op. margin 13.07%
Gross margin 33.71%
FCF margin 0.65%
Quality
78 /100
Excellent ROA 6.64%
ROIC 11.81%
Asset turnover 1.01x
Debt
54 /100
Moderate Int. coverage 3.89x
Debt/Equity 1.54x
Net debt/EBITDA 2.24x
Stability
57 /100
Moderate EPS volatility 1,088.24%
Beta 0.46x
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about PAHC
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Daniel Bendheim
Employees
2,605
Headquarters
Teaneck
Upcoming events
04 NOV
Earnings
Upcoming earnings report